One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Drug Abuse Testing Market

[ 英語タイトル ] Drug Abuse Testing Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0082302
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Abbott Laboratories
- Danaher Corporation (Beckman Coulter)
- LabCorp
- Dragerwerk AG & Co. KGaA
- Quest Diagnostics Inc.
- Randox Testing Services
- United States Drug Testing Laboratories Inc. (USDTL)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- F. Hoffmann-La Roche Ltd.

[Report Description]

The drug abuse testing market is expected to observe good growth due to the increasing demand for drug abuse treatment, stringent law mandating alcohol and drug testing, and rising drug-related mortality and increasing government initiative.

The use of drugs is found giving rise to a lot of illegal activities that consume a lot of resources of a country. These aspects have driven the governments of developed and emerging nations to take legal action against addicts and abusers. Therefore the developed countries such as the United States has stringent laws for drug abuse and have mandated the alcohol and drug testing. For the sake of limiting violence or accidents, drug and alcohol testing on the streets is becoming very common in developing as well as developed countries, which is, in turn, helping the growth of the overall market. Thus a growing trend witnessed in the drug abuse testing market is that leading players are enhancing their product portfolio through the addition of products and updating of software with new substances for drug abuse testing, in order to maintain their competency and market share.

Identifying drug testing strategies are also necessary, as they may lead to the adoption of drugs testing kits and devices, and thus, boost market growth. Other factors that are expected to affect the growth of this market positively, include increasing demand for drug addiction treatment, rising drug-related mortality, and growing government initiative. This market is also currently growing due to technological advancements, increased sensitivity, reduced times required for testing, and facilitated detection of newly developed designer drugs.

Key Market Trends

Analysis of Urine is Expected to be the Dominant Segment by Sample Type Over the Forecast Period

Drug testing by urine analysis has been suggested and in many cases implemented for workplace drug abuse, as well as in criminal justice cases, etc. There are setup of many laboratories that were established to perform urinalysis associated with methadone treatment that have had to greatly expand their capacities. In recent years, many new laboratories have sprung up to meet the demands for drug assays and clinical laboratories associated with medical centers, under economic pressures in recent years, that has begun to venture into drug testing. Therefore, the urine analysis segment of the market is expected to gain traction in the near future.

In addition, the technological developments in drug abuse testing, increasing number of death due to drug overdose, and growing demand for drug tests have led to the increasing use of urine analysis for drug abuse.

North America Region Holds the Largest Market Share of Drug Abuse Testing Market

North America has been accounted for the largest share in the drug abuse testing market, globally. Drug abuse is a serious problem that can lead to legal, financial, and health problems and the North America region is currently facing the same problem. Therefore, various initiatives are being implemented by the United States government to monitor the symptoms and to determine whether a population is abusing drugs. For instance, Patients and Communities Act of 2018 is the latest law implemented by the country for counter-acting drug abuse.

There is also a high contribution due to the adaptation of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, large scale drug trafficking, that is being responsible for the growth of the market.

Competitive Landscape

The leading players through acquisitions are attaining competency and larger market share in the global drug abuse testing industry. The major player in the DoA testing market includes Danaher Corporation, Siemens, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Quest Diagnostics Inc., LabCorp, Abbott Laboratories, ThermoFisher Scientific Inc, etc.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand For Drug Abuse Treatment
4.2.2 Stringent Law Mandating Alcohol and Drug Testing
4.2.3 Rising Drug Related Mortality and Increasing Government Initiative
4.3 Market Restraints
4.3.1 Perception of Drug Abuse Testing as a Violation of Rights
4.3.2 Lack of Awareness Regarding the Availability of Advanced Drug Testing Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product Type
5.1.1 Analyzers Immunoassays Analyzers Chromatographic Devices Breath Analyzers
5.1.2 Rapid Testing Devices Urine Testing Devices Oral Fluid Testing Devices
5.1.3 Consumables
5.2 By Sample Type
5.2.1 Saliva
5.2.2 Urine
5.2.3 Blood
5.2.4 Others
5.3 By End User
5.3.1 Hospitals
5.3.2 Diagnostic Laboratories
5.3.3 Forensic Laboratories
5.3.4 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Danaher Corporation (Beckman Coulter)
6.1.3 LabCorp
6.1.4 Dragerwerk AG & Co. KGaA
6.1.5 Quest Diagnostics Inc.
6.1.6 Randox Testing Services
6.1.7 United States Drug Testing Laboratories Inc. (USDTL)
6.1.8 Thermo Fisher Scientific Inc.
6.1.9 Siemens Healthineers AG
6.1.10 F. Hoffmann-La Roche Ltd.




Recommended reports